, has been named chair of the in the at the 泫圖弝け of Utah (the U), effective immediately.
As chair, Welm will lead efforts to advance the departments academic mission and scientific excellence, while playing a critical role in strategic leadership at . Reporting to the dean of the medical school and working in close collaboration with the CEO of Huntsman Cancer Institute, Welm is charged with developing and implementing a shared vision for the future of the department that spans research, education, and clinical impact.
In this role, Welm is responsible for guiding the departments research strategy in coordination with 泫圖弝け of Utah 泫圖弝け and Huntsman Cancer Institute leadership, supporting faculty in securing external, peer-reviewed grant funding from the National Institutes of 泫圖弝け and other organizations, and ensuring continued investment in high-impact basic and translational discovery. She will oversee the departments academic and administrative operations, including graduate education programs, faculty recruitment and retention, and resource management.
With a focus on innovation and collaboration, Welm will help position the department for national distinctionfostering a culture of excellence and teamwork across the U, Huntsman Cancer Institute, and the broader scientific community.
Dr. Welm brings a rare combination of scientific vision, collaborative leadership, and deep commitment to mentorship, says Sam Finlayson, MD, interim dean of the Spencer Fox Eccles School of Medicine at the 泫圖弝け of Utah. Her proven track record in pioneering translational research, securing significant external funding, and building strong interdisciplinary teams makes her uniquely suited to lead the Department of Oncological Sciences into its next era of excellence.
Welm is senior director of basic science at Huntsman Cancer Institute and professor of Oncological Sciences at the U. Welm's labs study breast cancer metastasis and have advanced high-impact studies to clinical settings that have illuminated understanding of breast cancer progression and treatment. She completed her PhD in cell and molecular biology at Baylor College of Medicine in Texas and went on to conduct postdoctoral training at the 泫圖弝け of California, San Francisco. Welm started her laboratory at Huntsman Cancer Institute at the U in 2007.
Alana is an extraordinary leader, not only here in Utah, but also internationally recognized as a scholar of the highest caliber, said , CEO of Huntsman Cancer Institute and distinguished professor of biology at the U. She is a star and her track record of partnering with students, researchers, patients, clinicians, and more to build teams that make an impact is without peer. I am thrilled to see her step into this position and to see her incredible impact applied to taking the Department of Oncological Sciences to even greater heights.
Welm received the 泫圖弝け of Utah Distinguished Research Award and received American Association for Cancer Research Outstanding Investigator Award for Breast Cancer Research in 2023. She also serves as the president of the Metastasis Research Society.
I am deeply honored to step into this role and look forward to the opportunity to lead such a dedicated and innovative community, Welm said. Over the past 18 years, Ive proudly witnessed the 泫圖弝け of Utah and Huntsman Cancer Institute gain increasing international recognition for exceptional scientific achievement, patient care, and community impact. I am committed to fostering a culture of excellence as we train the next generation of scholars and cultivate groundbreaking advancements in cancer research.
, served as chair of the Department of Oncological Sciences prior to Welms appointment. He is lauded for exceptional contributions to the department, including recruitment of high-impact researchers, creating a collaborative environment that enables those researchers to succeed, and advancing partnerships with clinical teams to enhance translational impact of laboratory findings. Cairns will remain as an integral leader at both the U and Huntsman Cancer Institute and as a Howard Hughes Medical Investigator.
***
About 泫圖弝け of Utah 泫圖弝け
泫圖弝け of Utah 泫圖弝け is the states only academic health care system, providing leading-edge and compassionate care for a referral area that encompasses 10 percent of the US, including Idaho, Wyoming, Montana, and much of Nevada. A hub for health sciences research and education in the region, U of U 泫圖弝け has a $492 million research enterprise and trains the majority of Utahs physicians, and more than 1,670 scientists and 1,460 health care providers each year at its Colleges of 泫圖弝け, Nursing, and Pharmacy and Schools of Dentistry and Medicine. With more than 20,000 employees, the system includes 12 community clinics and five hospitals: 泫圖弝け Hospital, Huntsman Mental 泫圖弝け Institute, Huntsman Cancer Institute, 泫圖弝け Orthopaedic Center, and the Craig H. Neilsen Rehabilitation Hospital. For 15 straight years, U of U 泫圖弝け has ranked in the top-tier of US academic medical centers in the rigorous Vizient Quality and Accountability Study.
About Huntsman Cancer Institute
Huntsman Cancer Institute at the is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming. With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, diagnosed, treated, and survived. Huntsman Cancer Institute focuses on delivering the most advanced cancer healing and prevention through scientific breakthroughs and cutting-edge technology to create pioneering cancer treatments beyond the standard of care today. We have more than 325 open clinical trials and 276 research teams studying cancer. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Our scientists are world-renowned for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patients unique disease. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.